Concepedia

Mary Gleason-Guzman

MG

Statistics

Publications

14

Citations

930

H-Index

13

Active since

1996

Affiliations

University of Arizona(Current)

Arizona Oncology

Institute of Pharmacology

The University of Texas at Austin

Moffitt Cancer Center

Mary Gleason-Guzman is an author at University of Arizona specializing in pharmacology, medicine, and chemotherapy.

Publications per year

1996–2010

14

Publications

14

The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.

Mu-Yong Kim, Mary Gleason-Guzman, Elżbieta Izbicka et al. · PubMed · 2003 · 207 citations

Life Sciences, Molecular Biology, Pharmacology +14

Selection for Drug Resistance Results in Resistance to Fas-Mediated Apoptosis

Terry H. Landowski, Mary Gleason-Guzman, William S. Dalton · Blood · 1997 · 159 citations · Full text

Life Sciences, Cell Biology, Pharmacology +13

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.

Lori Hazlehurst, Nils E. Foley, Mary Gleason-Guzman et al. · PubMed · 1999 · 115 citations

Medicine, Oncology, Pharmacology +14

Molecular Cloning of the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter and Drug Targeting of the G-Quadruplex-Forming Region To Repress PDGFR-β Expression

Yong Qin, Jessica S. Fortin, Denise Tye et al. · Biochemistry · 2010 · 76 citations

Life Sciences, Genetics, Molecular Biology +17

cDNA Microarray Analysis of Multidrug Resistance: Doxorubicin Selection Produces Multiple Defects in Apoptosis Signaling Pathways

George S. Watts, Bernard W. Futscher, R. Benjamin Isett et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 72 citations

Medicine, Oncology, Pharmacology +16

1–5 of 14